Answers are grounded in this paper and cite their sources.
Background: The COVID-19 pandemic has profoundly impacted pregnant women worldwide. Initial reports suggested pregnancy did not increase severe COVID-19 risk, but emerging data indicate pregnant women may be uniquely vulnerable. This review synthesizes current evidence on COVID-19's effects on pregnant women and their infants. Methods: A literature search was conducted in PubMed, Embase, and Scopus using keywords related to COVID-19 and pregnancy. Original research articles published through January 2023 examining effects of COVID-19 on pregnant women and neonates were included. Study quality was assessed using standardized criteria. Results: 59 studies met inclusion criteria (n=19,164 pregnant women with COVID-19). Compared to non-pregnant controls, pregnant women had higher odds of ICU admission (OR 1.62, 95%CI 1.33-1.96), mechanical ventilation (OR 1.88, 95%CI 1.36-2.60), and mortality (OR 1.62, 95%CI 1.33-1.96). Preterm birth was more likely (OR 1.47, 95%CI 1.14-1.91). Vertical transmission was uncommon (2.7%, 95%CI 1.73-4.21%). SARS-CoV-2 was detected in placenta (17%), amniotic fluid (5.7%), umbilical cord blood (5.8%), and breast milk (13%). Long-term data remain limited. Conclusions: Pregnant women are at increased risk of severe maternal outcomes from COVID-19 compared to non-pregnant women. Preterm birth is more likely. Vertical transmission occurs but appears rare. SARS-CoV-2 can be present in fetal compartments and breast milk. Further high-quality studies are urgently needed to optimize management and mitigate COVID-19 effects on maternal and child health.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: